# SINA ROSTAMI

<a href="https://drive.google.com/uc?export=view&id=1CeL7Y9G98JxgbyutEsfw4nIHeZf6-2qA"><img src="https://drive.google.com/uc?export=view&id=1CeL7Y9G98JxgbyutEsfw4nIHeZf6-2qA" style="width: 650px; max-width: 100%; height: auto" title="Click to enlarge picture" />
_Postdoc at the Cancer Registry of Norway_ <br>
[Email](mailto:rostami.sina1@gmail.com) / [Twitter](https://twitter.com/SinaRostami21)


## EDUCATION/RESEARCH
**Postdoc** @ [Cancer Registry of Norway](https://www.kreftregisteret.no/en/General/About-the-Cancer-Registry/Our-staff/sina-rostami//) _(March 2021 - Present)_ <br>
Project: Pre-diagnostic dynamics of small non-coding RNAs in endometrial cancer – impact of body mass index.
  - Aim: to investigate the role of small RNA’s in the development of endometrial cancer using pre-diagnostic samples from the Janus Serum Bank
 
**Researcher** @ [University of Oslo](https://www.mn.uio.no/farmasi/personer/vit/sinar/index.html) _(Nov 2020 - Present)_ <br>
Project: Construction of polygenic risk scores for psychiatric conditions in the Norwegian Mother, Father, and Child Cohort Study (MoBa).

**PhD Candidate and Researcher in Medicine** @ [NTNU – Norwegian University of Science and Technology, Trondheim, Norway](https://www.ntnu.edu/) _(September 2016 –June 2020)_ <br>
Research Topic: Construction and evaluation of the performance of genetic risk scores for ankylosing spondylitis, rheumatoid arthritis, and myocardial infarction in the Norwegian population-based Nord-Trøndelag Health Study (HUNT).

**MSc in Molecular Biology** @ [University of Bergen](https://www.uib.no/en) _(August 2014 – June 2016)_ <br>

Thesis title: Hemagglutinin-specific antibody responses following 2009 pandemic H1N1 influenza vaccination in healthcare workers

**BSc in Biology-Cellular and Molecular Sciences** @ [Ferdowsi University of Mashhad, Mashhad, Iran](https://en.um.ac.ir/) _(September 2008 - January 2013)_ <br>

## SCIENTIFIC PUBLICATIONS
1. 	_Rostami_ </u> , Hoff M, Dalen H, Hveem K, Videm V. **Genetic risk score associations for myocardial infarction are comparable in persons with and without rheumatoid arthritis – the population-based HUNT study**. Sci Rep. 2020;10(1):20416.
2.	_Rostami S_, Hoff M, Brown MA, Hveem K, Videm V. **Comparison of methods to construct a genetic risk score for prediction of rheumatoid arthritis in the population-based HUNT study, Norway**. Rheumatology (Oxford). 2020;59(7):1743-51.
3.	_Rostami S_, Hoff M, Brown MA, Hveem K, Holmen OL, Fritsche LG, Videm V. **Prediction of ankylosing spondylitis in the HUNT study by a genetic risk score combining 110 single-nucleotide polymorphisms of genome-wide significance**. J Rheumatol. 2020;47(2):204-10. 
4.	Tete SM, Jul-Larsen A, _Rostami S_, Lunde THF, Soland H, Krammer F, Cox RJ. **Impact of pre-existing immunity on the induction of functional cross- reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine**. Vaccine. 2018;36(16):2213-9.
5.	Peeridogaheh H, Meshkat Z, Habibzadeh S, Arzanlou M, Shahi JM, _Rostami S_, et al. **Current concepts on immunopathogenesis of hepatitis B virus infection**. Virus Res. 2018;245:29-43.
6.	Sepahi S, Pasdar A, Gerayli S, _Rostami S_, Gholoobi A, Meshkat Z. **CTLA-4 gene haplotypes and the risk of chronic hepatitis C infection; a case control study**. Rep Biochem Mol Biol. 2017;6(1):51-8.
7.	Gholoobi A, Meshkat Z, Baghani A, Alavi MS, Mohammadpoor T, Momen-Heravi M,…, _Rostami S_, et al. **Comparison of the prevalence of enteroviruses in blood samples of patients with and without unstable angina**. ARYA Atheroscler. 2017;13(4):161-6.
8.	Teimourpour R, Tajani AS, Askari VR, _Rostami S_, Meshkat Z. **Designing and development of a DNA vaccine based on structural proteins of hepatitis C virus**. Iran J Pathol. 2016;11(3):222-30.
9.	Ghasemi F, _Rostami S_, Nabavinia MS, Meshkat Z. **Developing Michigan cancer foundation 7 cells with stable expression of E7 gene of human papillomavirus type 16**. Iran J Pathol. 2016;11(1):41-6.
10.	Ghasemi F, _Rostami S_, Ghayour-Mobarhan M, Meshkat Z. **Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection**. Iran J Basic Med Sci. 2016;19(7):692-704.
11.	Gerayli S, Pasdar A, Shakeri MT, Sepahi S, Hoseini SM, Ahadi M, _Rostami S_, Meshkat Z. **Haplotype analysis of hemochromatosis gene polymorphisms in chronic hepatitis C virus infection: A case control study**. Iran Red Crescent Med J. 2016;18(6):e24675.
12.	Teimourpour R, Meshkat Z, Gholoubi A, Nomani H, _Rostami S_. **Viral load analysis of hepatitis C virus in Huh7.5 cell culture system**. Jundishapur J Microbiol. 2015;8(5):e19279.
13.	Salehpour M, Tayyebi Meibodi N, Teimourpour R, Ghorani-Azam A, Sepahi S, _Rostami S_, Meshkat Z. **Frequency of human papillomavirus genotypes 6, 11, 16, 18 and 31 in paraffin-embedded tissue samples of invasive breast carcinoma, Northeast of Iran**. Iran J Pathol. 2015;10(3):192-8.
14.	Sadeghian H, Varasteh N, Esmaeelzadeh A, Nomani H, Alimardani M, Davoodnejad M,…,_Rostami S_, et al. **Distribution of hepatitis delta virus genotypes in Mashhad, Northeast Iran**. Jundishapur J Microbiol. 2015;8(2):e14908.
15.	Nabavinia MS, _Rostami S_, Ghasemi F, Meshkat Z. **Application of McCoy cell line for propagation of herpes simplex virus type 1**. Iran J Med Sci. 2015;40(3):268-71.
16.	Mirbagheri SZ, Meshkat Z, Naderinasab M, _Rostami S_, Nabavinia MS, Rahmati M. **Study on imipenem resistance and prevalence of blaVIM1 and blaVIM2 metallo-beta lactamases among clinical isolates of Pseudomonas aeruginosa from Mashhad, Northeast of Iran**. Iran J Microbiol. 2015;7(2):72-8.
17.	Ghasemi F, _Rostami S_, Meshkat Z. **Progress in the development of vaccines for hepatitis C virus infection**. World J Gastroenterol. 2015;21(42):11984-2002.
18.	Sepahi S, Pasdar A, Ahadi M, Gerayli S, _Rostami S_, Meshkat Z. **Haplotype analysis of interleukin-10 gene promoter polymorphisms in chronic hepatitis C infection: a case control study**. Viral Immunol. 2014;27(8):398-403.
19.	Afshari R, Nomani H, Zaniani FR, Nabavinia MS, Mirbagheri Z, Meshkat M,…, _Rostami S_, et al. **Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran**. Turk J Med Sci. 2014;44(4):656-60.
20.	Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, _Rostami S_, Meshkat Z. **The prevalence of hepatitis C virus in Mashhad, Iran: a population-based study**. Hepat Mon. 2013;13(3):e7723.
21.	Shakeri MT, Foghanian B, Nomani H, Ghayour-Mobarhan M, Nabavinia MS, _Rostami S_, et al. **The prevalence of hepatitis B virus infection in Mashhad, Iran: a population-based study**. Iran Red Crescent Med J. 2013;15(3):245-8.


## Languages

**English**: Full professional working proficiency <br>
**Norwegian**: B2/C1 <br>
**Persian**: Native
<br><br>
